Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Assets (2018 - 2025)

Dianthus Therapeutics (DNTH) has 6 years of Return on Assets data on record, last reported at 0.29% in Q3 2025.

  • For Q3 2025, Return on Assets fell 10.0% year-over-year to 0.29%; the TTM value through Sep 2025 reached 0.29%, down 10.0%, while the annual FY2024 figure was 0.31%, 3.0% up from the prior year.
  • Return on Assets reached 0.29% in Q3 2025 per DNTH's latest filing, up from 0.34% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.15% in Q2 2024 and bottomed at 0.62% in Q1 2023.
  • Average Return on Assets over 4 years is 0.35%, with a median of 0.32% recorded in 2023.
  • Peak YoY movement for Return on Assets: fell -21bps in 2023, then skyrocketed 44bps in 2024.
  • A 4-year view of Return on Assets shows it stood at 0.55% in 2022, then surged by 57bps to 0.23% in 2023, then rose by 1bps to 0.23% in 2024, then fell by -25bps to 0.29% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.29% in Q3 2025, 0.34% in Q2 2025, and 0.28% in Q1 2025.